WebbNiKang Therapeutics is an early stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet … http://nikangtx.com/
Goran Kecman - Project Manager - /// LinkedIn
WebbMorrison Foerster > The Legal 500 Rankings Hong Kong > Investment funds Tier 2 ‘Best in class in advising on complex fund formation matters’, Morrison Foerster displays a ‘perfect combination of sector expertise, technical knowledge, and commercial savviness’ for GPs and LPs, in relation to closed end funds. Private equity/venture capital instructions … WebbNifco Taiwan Corporation. 2015 年 9 月 - 目前7 年 8 個月. Taiwan. 1.Present, promote and sell products/services to existing and prospective customers. 2.Perform cost-benefit and needs analysis of existing/potential customers to meet their needs. 3.Establish, develop and maintain positive business and customer relationships. jd mccrary facebook
NiKang, Pfizer partner to evaluate NKT2152 in renal cell carcinoma
WebbCooley LLP is an undoubted market leader for all forms of venture capital and emerging companies work. The ‘great team‘ is widely considered by clients to be an ‘extension of the business‘ and a ‘great business partner to a company that does not have in-house legal counsel‘.The balanced practice acts for a wide mix of early-to-late stage companies, … WebbNiKang Therapeutics has raised a total of $260M in funding over 3 rounds. Their latest funding was raised on May 26, 2024 from a Series C round. NiKang Therapeutics is funded by 24 investors. EcoR1 Capital and Lilly Asia Ventures are the most recent investors. Funding Rounds Number of Funding Rounds 3 Total Funding Amount $260M WebbNiKang Therapeutics is an early stage biotech company focused on discovering and developing small molecule oncology medicines to help patients with unmet medical needs. ... She has also held leadership positions in Oncology Drug Development at KaloBios Pharmaceuticals, Talon Therapeutics (formerly Hana Biosciences), ... lth zoom login